Article
Tongue advancement – first results of a novel surgical treatment for retrolingual obstruction
Search Medline for
Authors
Published: | July 8, 2008 |
---|
Outline
Text
Introduction: retrolingual obstruction in obstructive sleep apnoea is an unsolved issue in many ways, especially as the current surgical strategies are of limited efficacy or of significant morbidity. Aim of the study was to investigate a novel surgical approach in terms of titratable tongue advancement.
Methods: 22 patients with obstructive sleep apnoea (AHI>15, BMI<32) and isolated retrolingual obstruction were included in this prospective bicenter trial. A titanium tissue anchor was implanted into the tongue (Tongue Advancement, Aspire Medical) in general anaesthesia via a cervical approach and was fixed to a titratable spool at the mandible. After an adequate healing period, the tension on the system was modified at the spool under local anaesthesia if necessary. Postoperative pain was assessed with a patient diary (VAS 0-10). Before and 2 months after implantation three home sleep studies were performed and daytime sleepiness was assessed (ESS)
Results: Due to technical defects or malpositioning of the system the tissue anchor had to be removed in 4 out of 9 cases with the first and in 1 out of 13 cases with a modified system. Mild complications occurred in 5 out of 22 cases. Pain after implantation was moderate with a VAS of 4.3±2.7 (day 1) and 0.7±0.9 (day 5). Impairment of functional aspects did not occur. The AHI was reduced from 27.1±8.1 to 9.5±7.8 (n=14), the ESS improved from 12.7±5.4 to 6.9±5.5.
Conclusion: tongue advancement is an interesting alternative in the surgical treatment of obstructive sleep apnoea. Technical problems that appeared with the initial system were overcome with a modified device. Postoperative morbidity is limited, especially the ability for titration after implantation appears promising.